Cargando…
Life threatening angioedema in a patient on ACE inhibitor (ACEI) confined to the upper airway
Introduction: ACE inhibitors accounts for 8% of all cases of angioneurotic edema and the overall incidence is 0.1 to 0.7% of patients on ACE inhibitors. It is a leading cause (20-40%) of emergency room visits in the US with angioedema. We report a case of angioedema caused by ACE inhibitors confined...
Autores principales: | Tharayil, Abdulgafoor Muslim, Chanda, Arshad Hussain, Shiekh, Hakim Ahmad, Elkhatib, Mohamed Saad, Nayeemuddin, Mohammed, Alshamandy, Abdelhafiz Ali Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bloomsbury Qatar Foundation Journals
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344982/ https://www.ncbi.nlm.nih.gov/pubmed/25745598 http://dx.doi.org/10.5339/qmj.2014.15 |
Ejemplares similares
-
Assembly and regulation of the chlorhexidine-specific efflux pump AceI
por: Bolla, Jani Reddy, et al.
Publicado: (2020) -
Regulation of the aceI multidrug efflux pump gene in Acinetobacter baumannii
por: Liu, Qi, et al.
Publicado: (2018) -
ACE inhibitor angioedema: characterization and treatment versus non-ACE
angioedema in acute hospitalized patients
por: Weisman, David S., et al.
Publicado: (2020) -
ACE Inhibitor-Induced Angioedema of the Bowel
por: Campbell, Tabitha, et al.
Publicado: (2010) -
Angioedema, ACE inhibitor and COVID-19
por: Grewal, Ekjot, et al.
Publicado: (2020)